在手术切除的表皮生长因子受体突变肺癌中,MDM2表达的预后含义与病态淋巴结转移的淋巴结转移
Tetsuya Isaka1,2, Yohei Miyagi3, Rika Kasajima3
1Department of Thoracic Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Translational lung cancer research
|August 13, 2025
概括
在EGFR突变和淋巴结转移的肺腺癌患者中,MDM2蛋白表达是有利的预后因素. 较高的MDM2水平与改善的无复发生存率和整体生存率相关,特别是在Ex21亚型中.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- MDM2蛋白调节p53活动,但其在原发性肺癌的预后意义尚不清楚.
- 这项研究的重点是表皮生长因子受体突变 (EGFRm) 肺腺癌与病态淋巴结转移.
研究的目的:
- 为了研究MDM2蛋白表达在EGFRm肺腺癌患者的预后影响,淋巴结转移.
- 评估MDM2作为预测术后预后和远程转移的潜在生物标志物.
主要方法:
- 在124个手术切除的pN1-N2EGFRm肺癌中对MDM2表达的免疫组合化学分析 (Exon 19删除和Exon 21 L858R突变).
- 术后预后和复发的累积发病率的回顾性分析.
主要成果:
- 阳性MDM2 (56/124名患者) 与明显更好的5年无复发存活率 (RFS) (35.5%对14.8%,P=0.04) 相关.
- MDM2阳性是RFS的一个独立的有利预后因素 (HR,0.64;P=0.04).
- 在Ex21 EGFRm肺癌患者中,MDM2阳性显著改善了RFS和整体存活率 (OS),并减少了远程和中枢神经系统复发.
结论:
- 在 pN1-N2 Ex21 EGFRm 肺癌手术后,MDM2 蛋白质表达预测了有利的 RFS 和 OS.
- MDM2作为预测术后预后和远程转移,特别是中枢神经系统复发的新型生物标志物.
相关概念视频
02:38Mitogens and the Cell Cycle
6.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.7K
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K